Interventional device developer Boston Scientific said that it has acquired privately held medical device developer EndoTex Interventional Systems of Cupertino, CA.
The acquisition follows the U.S. Food and Drug Administration's approval of EndoTex's NexStent carotid stent system, which was studied in the same clinical trial as Natick, MA-based Boston Scientific's FilterWire EZ embolic protection system.
Terms of the acquisition were not disclosed.
By AuntMinnie.com staff writers
January 4, 2007
Related Reading
Boston Scientific receives FDA nod for FilterWire EZ, December 14, 2006
Boston Scientific, GE integrate informatics apps, November 9, 2006
Boston to bring Liberte to Japan, November 6, 2006
Boston Scientific supports STENT thrombosis study, October 24, 2006
Boston nets CE mark, October 16, 2006
Copyright © 2007 AuntMinnie.com
